-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
4D Molecular Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2025.
- 4D Molecular Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 56.1M shares, a 1.03% increase year-over-year.
- 4D Molecular Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 53.9M shares, a 37.9% increase from 2023.
- 4D Molecular Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 39.1M shares, a 21% increase from 2022.
- 4D Molecular Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 32.4M shares, a 16.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)